Product Details:
| Minimum Order Quantity | 10 Piece |
| Packaging Size | 250mcg /120 meterdose |
| Brand | seroflo inhaler |
| Composition | Salmeterol (25mcg) + Fluticasone Propionate (250mcg) |
| Treatment | asthama |
| Prescription/Non prescription | Non prescription |
| Form | Inhaler |
| Shelf life | 2 year |
| Product Type | Inhaler |
| Medicine Type | inhaler |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 unit |
| Packaging Size | 200 MDI IN 1 PACKET |
| Brand | ASTHALIN INHALER |
| Composition | SALBUTAMOL INHALATION IP |
| Treatment | Asthama |
| Prescription/Non prescription | Non prescription |
| Shelf life | 36 months |
| Medicine Type | Inhaler |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Piece |
| Packaging Size | 1 piece |
| Brand | gsk |
| Treatment | as prescribed by doctor |
| Prescription/Non prescription | Non prescription |
| Form | inhaletr |
| Shelf life | 36 months |
| PACKING OR STRIP | bottle |
Trelegy Ellipta is used to treat COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema, and is also used for asthma in adults as a maintenance treatment. Trelegy Ellipta is used daily to improve symptoms and prevent bronchospasm in adults with COPD, and for adults with asthma, it is used daily to prevent and control symptoms of asthma.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Pack |
| Packaging Size | 1 Pack |
| Brand | Trelegy Ellipta Inhaler |
| Composition | Fluticasone Furoate (100mcg) + Umeclidinium (62.5mcg) + Vilanterol (25mcg) |
| Treatment | Chronic obstructive pulmonary disease (COPD) |
| Form | Inhaler |
| Shelf life | 24 MONTHS |
Fluticasone Furoate (100 mcg) + Umeclidinium (62.5 mcg) + Vilanterol (25 mcg)
This combination is an inhalation medication used for long-term management of chronic respiratory diseases. It contains:
Fluticasone Furoate: a corticosteroid that reduces inflammation in the airways.
Umeclidinium: a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles.
Vilanterol: a long-acting beta₂ agonist (LABA) that helps open air passages.
Main Uses:
Chronic Obstructive Pulmonary Disease (COPD):
Used for maintenance treatment to reduce symptoms like shortness of breath, wheezing, and coughing.
Helps prevent COPD flare-ups and improves lung function.
Asthma (in adults and adolescents):
Used for long-term control of asthma when symptoms are not adequately managed with other inhalers.
Reduces airway inflammation and keeps airways open for easier breathing.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Piece |
| Strength | 100 mcg |
| Composition | Budesonide inhalation ip 100 mcg dose |
| Packaging Size | 200 MDI |
| Brand | Budecort |
| Manufacturer | Cipla Ltd |
| Form | Metered dose Inhaler |
| Packaging Type | Box |
| Country of Origin | Made in India |
Budesonide is a corticosteroid (inhaled steroid/ICS) used for long-term control of asthma and certain lung conditions.
"IP" means Indian Pharmacopoeia – the drug is manufactured and tested according to Indian standards.
Each actuation (puff) of the inhaler delivers 100 micrograms (mcg) of budesonide directly to the lungs.
Asthma and chronic airway disease involve inflammation and swelling of the airways.
Budesonide works by:
Reducing inflammation in the airways
Decreasing mucus production
Preventing airway hyper-responsiveness (over-sensitivity to triggers)
It does not provide immediate relief of breathing difficulty; instead, it controls symptoms with regular use over time.
Asthma (maintenance therapy)
Prevents wheezing, coughing, chest tightness, shortness of breath.
Usually prescribed for long-term control.
Chronic Obstructive Pulmonary Disease (COPD) (in some cases).
Allergic rhinitis / nasal polyps (in nasal spray form, not the inhaler).
Sometimes used in bronchitis-related airway inflammation.
Typical adult starting dose (via inhaler): 200–400 mcg per day, divided into 2–4 doses.
For children: 100–200 mcg/day (depending on severity and doctor’s advice).
Maximum dose depends on patient’s age, severity, and clinical response.
Important: The inhaler must be used regularly (daily) for best results, even if symptoms are not present.
Shake the inhaler well.
Exhale fully.
Place mouthpiece in mouth, press down to release a puff, and inhale deeply.
Hold breath for ~10 seconds, then exhale slowly.
Rinse mouth with water after each use → prevents oral fungal infection (thrush).
Common:
Hoarseness of voice
Sore throat, throat irritation
Oral thrush (fungal infection)
Mild cough after inhalation
Less common but important:
Delayed growth in children (rare, dose-dependent)
Long-term use may cause adrenal suppression (very rare at inhaled doses)
Eye problems (glaucoma, cataract) with prolonged high-dose use
Not a rescue inhaler → does not relieve sudden asthma attack (for that, Salbutamol/Albuterol inhalers are used).
Use regularly, not just when symptoms occur.
Rinse mouth after every dose.
Inform doctor if you have tuberculosis, fungal, or viral infections, as steroids may worsen them.
✅ In summary:
Budesonide Inhalation IP 100 mcg is a preventive inhaled steroid used in asthma and airway inflammation. It helps control symptoms and prevent attacks when taken daily, but it does not work as an emergency reliever.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Piece |
| Strength | 200 mcg |
| Packaging Size | 120 MDI |
| Brand | Budecort |
| Manufacturer | Cipla Ltd |
| Form | Metered dose Inhaler |
| Composition | BUDESONIDE 200 MCG |
| Packaging Type | Box |
| Country of Origin | Made in India |
Generic name: Budesonide
Strength: 200 mcg (micrograms) per dose (common in inhalers, rotacaps, or nebulizer suspensions)
Class: Inhaled corticosteroid (ICS)
Primary use: Long-term control of asthma and Chronic Obstructive Pulmonary Disease (COPD); also used in some allergic rhinitis and inflammatory bowel disease (oral formulations).
Inhalers / Rotacaps / Turbuhalers: Each puff or capsule delivers 200 mcg of budesonide to lungs.
Nebulizer suspension: Often available in unit doses (e.g., 0.5 mg/2 ml = 500 mcg; adjusted for pediatric/adult use).
Not oral tablets/capsules at this dose → those are higher (e.g., 3 mg capsules for Crohn’s disease).
Budesonide is a glucocorticoid that acts locally in the lungs.
It binds to glucocorticoid receptors → reduces release of inflammatory mediators like prostaglandins, leukotrienes, cytokines.
↓ Airway inflammation, mucus production, and hyperresponsiveness.
Leads to better airflow and fewer asthma/COPD attacks.
Asthma (maintenance therapy) → prevents symptoms such as wheezing, breathlessness, coughing.
COPD (with frequent exacerbations, usually in combination with LABA like formoterol).
Allergic rhinitis (as nasal spray, though usual dose is 64 mcg/spray).
⚠️ Not a rescue medication → does not provide immediate relief (that’s for bronchodilators like salbutamol).
🔹 Dosage (Typical)Adults (Asthma): 200–800 mcg/day, divided into 1–2 doses.
Starting dose may be 200 mcg twice daily.
Severe cases: up to 1600 mcg/day.
Children (6–12 years): 200–400 mcg/day (max 800 mcg/day).
Doses are individualized based on severity and response.
Local (more common):
Hoarseness of voice
Throat irritation
Oral thrush (candidiasis) → prevent by rinsing mouth after inhalation
Systemic (rare, at high/prolonged dose):
Adrenal suppression
Osteoporosis
Cataract, glaucoma (long term)
Slowed growth in children (monitor carefully)
Not for acute asthma attack.
Use with caution in patients with:
Active pulmonary infections (TB, fungal, viral)
Hepatic impairment (metabolized in liver, CYP3A4 pathway)
Must taper gradually if stopping after long-term use.
Onset: 2–8 days for noticeable improvement; full benefit may take weeks.
Half-life: ~2–3 hours (systemic), but inhaled drug has prolonged local effect.
Metabolism: Hepatic (CYP3A4), extensive first-pass metabolism → very low oral bioavailability when swallowed (good for safety in inhaled use).
Pulmicort (AstraZeneca)
Budecort (Cipla)
Respules (for nebulization)
Symbicort (when combined with Formoterol)
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Piece |
| Packaging Size | 120 MDI |
| Packaging Type | Pack |
| Brand | SEROFLO 125 INHALER |
| Manufacturer | CIPLA |
| Shelf Life | 24 month |
| Country of Origin | Made in India |
This is a fixed-dose combination inhaler used in the management of asthma and chronic obstructive pulmonary disease (COPD).
Salmeterol (50 mcg): A long-acting beta-2 adrenergic agonist (LABA).
Fluticasone Propionate (250 mcg): A corticosteroid (anti-inflammatory medicine).
This dual action provides bronchodilation (relaxing airway muscles) and anti-inflammatory effects (reducing swelling and mucus in the airways).
�� CompositionSalmeterol xinafoate equivalent to 50 mcg of Salmeterol
Fluticasone propionate 250 mcg
Delivered via dry powder inhaler (DPI) or metered dose inhaler (MDI)
Salmeterol (LABA):
Binds to β2-receptors in bronchial smooth muscle.
Produces bronchodilation for up to 12 hours, preventing bronchospasm and wheezing.
Helps improve airflow and breathing.
Fluticasone Propionate (ICS – Inhaled Corticosteroid):
Reduces airway inflammation, edema, and mucus secretion.
Prevents exacerbations and long-term airway damage.
Enhances the effect of Salmeterol when used together.
Together → They control symptoms and prevent asthma attacks / COPD flare-ups.
�� IndicationsAsthma (moderate to severe, persistent) → when inhaled corticosteroids alone are insufficient.
COPD with reversible component → particularly in patients with frequent exacerbations and airflow limitation.
1 inhalation twice daily (morning and evening).
Dose adjustments depend on severity.
Pediatric use may vary (usually fluticasone 100 mcg + salmeterol 50 mcg for children).
⚠️ Must be taken regularly, not as a rescue inhaler.
�� Side EffectsCommon:
Hoarseness of voice, sore throat
Oral thrush (candidiasis)
Headache, cough
Muscle cramps, palpitations
Serious (rare):
Paradoxical bronchospasm (worsening breathing immediately after use)
Systemic corticosteroid effects if used at high dose for long (adrenal suppression, osteoporosis, growth retardation in children)
Rinse mouth after inhalation to prevent oral thrush.
Not for acute asthma attack (use rescue inhaler like Salbutamol).
Use with caution in:
Cardiovascular disease (can cause tachycardia, palpitations)
Patients prone to infections (steroid may mask infection signs)
Diabetes (steroid may increase blood sugar)
Taper gradually if discontinuing (to avoid withdrawal).
Seretide Accuhaler / Evohaler (GSK)
Seroflo (Cipla)
Salflumet, Airtec, Foracort (various Indian companies)
Additional Information: